000403 派林生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产262-5.07%276305333362
固定资产1,765,907-3.55%1,830,9021,462,343942,994873,673
在建工程246,4309.05%225,989513,359582,700385,735
无形资产181,477-4.60%190,220200,333212,593192,516
商誉2,536,0100.00%2,536,0102,614,6122,614,6122,614,612
其他非流动资产1,139,94518.50%961,944876,369851,167868,452
5,870,0302.17%5,745,3415,667,3215,204,3994,935,349

流动资产
货币资金812,1825.46%770,1581,321,1241,429,3501,000,797
应收账款754,480-18.84%929,584631,222583,579835,877
存货1,903,50821.75%1,563,4741,233,249909,375623,689
其他流动资产444,479-2.91%457,793393,354503,771586,612
3,914,6495.20%3,721,0083,578,9493,426,0753,046,976

流动负债
短期借款741,38838.40%535,704310,489250,571275,102
应付票据52,5371,218.37%3,9853,93200
应付帐款153,6451.57%151,275220,324154,347158,370
其他流动负债338,935-22.53%437,520422,226517,276525,837
1,286,50514.00%1,128,483956,972922,195959,309
流动资产净值2,628,1441.37%2,592,5252,621,9772,503,8802,087,667
资产总额减流动负债8,498,1741.92%8,337,8668,289,2987,708,2807,023,016

非流动负债
长期借款375,99093.98%193,828303,221196,07952,886
应付债券0--0000
其他非流动负债72,03814.73%62,78868,57390,337109,002
448,02874.59%256,617371,795286,416161,888

总权益
    实收股本950,3970.00%950,397731,075733,001732,387
    储备项目7,105,855-0.45%7,137,6307,193,5766,695,6496,135,137
股东权益8,056,252-0.39%8,088,0277,924,6517,428,6496,867,524
非控股权益(6,106)-9.93%(6,779)(7,148)(6,785)(6,397)